BioProtect, a company providing biodegradable spacing solutions, recently announced it closed its most recent funding round with $28 million from investors. The round was led by MVM Partners, with participation from Triventures, KB Investments, Peregrine Ventures, Almeda Ventures, and Consensus Business Group of Vincent Tchenguiz.

BioProtect是一家提供可生物降解间距解决方案的公司，最近宣布以投资者2800万美元关闭最近一轮资金。该轮由MVM合作伙伴领导，参与了Triventures，KB Investments，Peregrine Ventures，Almeda Ventures和Vincent Tchenguiz的Consensus Business Group。

The proceeds will help support BioProtects United States commercialization of its FDA cleared BioProtect Balloon Implant System for rectal protection during prostate cancer radiation therapy..

这些进展将有助于支持BioProtects美国商业化其FDA批准的BioProtect球囊植入系统，用于前列腺癌放射治疗期间的直肠保护。。

The balloon implant system is an implantable, biodegradable balloon that provides a defined, enclosed distance to reduce radiation exposure to the rectum. It is deployed in a quick and minimally invasive procedure using a blunted tip insertion device and is visible under all imaging modalities, including CT, MRI, and ultrasound..

球囊植入系统是可植入的，可生物降解的球囊，其提供限定的封闭距离以减少对直肠的辐射暴露。它使用钝头插入装置以快速和微创的方式部署，并且在所有成像模式下都可以看到，包括CT，MRI和超声波。。

'We believe that our balloon has the potential to revolutionize rectal protection from radiation toxicity during prostate cancer radiation therapy,' said Itay Barnea, CEO of BioProtect. 'To-date, our spacer has been successfully implanted in over 2,000 patients worldwide and has proven to be safe and effective.

BioProtect首席执行官Itay Barnea说：“我们相信，在前列腺癌放射治疗过程中，我们的气球有可能彻底改变直肠保护免受辐射毒性的影响。”迄今为止，我们的垫片已成功植入全球2000多名患者，并被证明是安全有效的。

We appreciate the support of our new and existing investors who share our vision for the company and are pleased to secure the resources to drive our penetration into the US market.'.

我们感谢我们新的和现有投资者的支持，他们分享了我们对公司的愿景，并很高兴获得资源来推动我们进入美国市场。

The company reported that it will officially launch the balloon technology at the 2023 annual meeting of the American Society of Therapeutic Radiology and Oncology in San Diego, CA, Oct. 1 to 4.

该公司报告称，它将于10月1日至4日在加利福尼亚州圣地亚哥举行的美国治疗放射与肿瘤学会2023年会上正式推出气球技术。